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Abstract
Background: Previously we found that Rad54/Rad54B cells are more sensitive towards mitomycin C (MMC) as
compared to wild-type (WT) cells. This difference in sensitivity was absent upon exposure to other clastogens like
bleomycin (BLM) and g-radiation. In order to get further insight into possible underlying mechanisms, gene
expression changes in WT and Rad54/Rad54B MEFs (mouse embryonic fibroblasts) after exposure to the clastogens
MMC and BLM were investigated. Exposures of these cells to mutagens (N-ac-AAF and ENU) and vehicle were
taken as controls.
Results: Most exposures resulted in an induction of DNA damage signaling and apoptosis genes and a reduced
expression of cell division genes in cells of both genotypes. As expected, responses to N-ac-AAF were very similar
in both genotypes. ENU exposure did not lead to significant gene expression changes in cells of both genotypes,
presumably due to its short half-life. Gene expression responses to clastogens, however, showed a genotype-
dependent effect for BLM and MMC. MMC treated Rad54/Rad54B MEFs showed no induction of p53-signaling, DNA
damage response and apoptosis as seen for all the other treatments.
Conclusion: These data support our finding that different types of clastogens exist and that responses to these
types depend on the DNA repair status of the cells.
Background
DNA double-strand breaks (DSBs) have detrimental
effects on the integrity of chromosomes and cell viabi-
lity. Unrepaired or incorrectly repaired DSBs can lead to
loss of chromosomes or cell cycle arrest which may lead
to uncontrolled cell growth, cell death or carcinogenesis
[1,2]. DSBs mainly arise through exogenous DNA-dama-
ging agents (clastogens) and endogenous sources. Clas-
togens can be divided into compounds that induce
single/double-strand breaks, like bleomycin (BLM) and
g-radiation, and compounds that induce interstrand
crosslinks (ICLs), like mitomycin C (MMC). The latter
are extremely cytotoxic [3].
The clastogenic potential of chemicals can be tested
with different types of genotoxicity assays. In previous
studies we measured the lacZ mutant frequencies (lacZ
MF) in both wild-type (WT) and DNA repair-deficient
Rad54/Rad54B MEFs derived from mice carrying the
lacZ gene in a plasmid vector. Cells were treated with
both mutagenic (causing gene mutations) and clasto-
genic (causing chromosome aberrations) compounds
[4]. The Rad54/Rad54B MEFs have a defect in the
Rad54 and the Rad54B genes (both involved in Homo-
logous Recombination (HR) repair), which we assume
m a yc a u s eas h i f ti nt h er e p a i ro fs i n g l e -o rd o u b l e -
strand breaks from HR repair towards non-homologous
end-joining (NHEJ) repair, which is an error-prone
repair system. This presumed shift between repair sys-
tems might cause an accumulation of chromosomal
damage induced by clastogens. Since Rad54/Rad54B
cells have a defect in HR repair, it is to be expected
that upon clastogen exposure these cells will accumulate
higher lacZ mutant frequencies (MF) as compared to
WT cells.
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well as Rad54/Rad54B MEFs were able to detect gene
mutations and chromosomal aberrations. Surprisingly,
of the clastogens used (BLM and MMC), only MMC
showed a genotype-dependent effect; Rad54/Rad54B
MEFs were more sensitive towards MMC treatment as
compared to the WT MEFs [4]. Bleomycin (BLM)
induced DNA lesions which could be repaired equally
effective in cells without active HR repair compared to
WT cells, whereas mitomycin C (MMC) showed a dif-
ferential effect in repair-deficient cells compared to WT
cells. This confirms the difference in DNA damage
caused by the clastogens, chromosomal breaks (BLM)
versus cross linking (MMC).
As different types of clastogens result in genotype-
dependent differences in genotoxic sensitivity, we
hypothesized that these compounds also trigger separate
pathways of (geno)toxicity in the two genotypes. Hence,
we further investigated whether different clastogens also
led to specific different changes in gene expression pat-
terns upon exposure, and thus if indeed different types of
clastogens exist. To this end, we performed microarray
analysis with WT and Rad54/Rad54B MEFs treated with
the clastogens: MMC and BLM, and the mutagens: N-
acetoxy-2-acetylaminofluorene (N-ac-AAF) and N-ethyl-
N-nitrosourea (ENU). The two mutagens were included
as controls aimed at distinguishing general genotoxicity
responses as well as genotype-independent responses
specific to either clastogens or mutagens. The outcome
of our studies confirms our hypothesis that different clas-
togens lead to specific gene expression changes and
moreover the responses are genotype specific.
Methods
Isolation of mouse embryonic fibroblasts (MEFs)
Embryos of 13.5 days were harvested from wild-type
(WT) and Rad54/Rad54B repair-deficient (Rad54/
Rad54B) mice. All mice were in a C57/BL6 genetic
background and were bred and maintained under speci-
fic pathogen-free conditions at the animal facility of the
Netherlands Vaccine Institute (NVI, Bilthoven, The
Netherlands). All animal experiments were approved by
the Institute’s Animal Ethics Committee and were car-
ried out in accordance with Dutch and international leg-
islation. The liver and head were discarded from the
embryonic body (to avoid disturbance during fibroblast
growth). The remainder of the embryonic body was
trypsinised and cultured in a 75 cm
2 flask containing 15
ml culture medium (Dulbecco’s Modified Eagle Medium
(DMEM) completed with 1% Modified Eagles Medium
Non-Essential Amino Acids (MEM NEAA), 1% Penicil-
lin-Streptomycin (PS) and 10% Fetal Bovine Serum
(FBS)) at 37°C in a humidified atmosphere containing
3% O2 and 10% CO2 for 3 days.
After 3 days, the cells were trypsinised, equally divided
over two 175 cm
2 culture flasks, and were grown for
another 4 days. Thereafter, the cells were collected
using trypsin and counted in a Bürker-Türk. After cen-
trifugation at 1200 rpm and 4°C for 5 minutes, the cell
pellet was resuspended in freezing medium (DMEM
completed with 20% FBS. 10% dimethylsulfoxide
( D M S O ) ,1 %M E MN E A Aa n d1 %P S )a tac o n c e n t r a -
tion of 3 × 10
6 cells per ml while keeping it on ice. One
ml portions were kept at -80°C for at least 24 hours and
were then stored in liquid nitrogen.
Treatment of MEFs
For each compound and each assay, aliquots of 3 × 10
6
cells of both genotypes were seeded and cultured in a
175 cm
2 flask containing 30 ml culture medium.
Twenty-four hours before treatment, the cells were dis-
sociated with trypsin and cultured into petridishes con-
taining 1 × 10
6 cells and a final volume of 10 ml culture
medium.
On the day of treatment, the cells were washed once
with D-PBS (Dulbecco’s phosphate-buffered saline, con-
taining KCl, KH2PO4,N a C l ,N a 2HPO4, without calcium
and magnesium) before treatment with the various gen-
otoxic compounds (see Table 1). Untreated MEFs were
used as a control. The concentration of each compound
was chosen from previously obtained survival data of
both WT as well as Rad54/Rad54B MEFs treated with
the different compounds [4]. In the XTT test, these con-
centrations resulted in approximately 80% survival.
The compounds were dissolved in the appropriate sol-
vent (see Table 1) on the day of treatment. The cells
were treated with the different compounds in a final
volume of 4 ml for 3 hours. After treatment, the cells
were washed once with D-PBS and cultured in 10 ml
culture medium for an additional 5 hours before collect-
ing them for RNA isolation. Thereafter, the cells were
washed once with D-PBS. The cells were dissociated
with 750 μl RLT-buffer using a cell scraper and were
collected in a 2 ml tube and stored overnight at -80°C
until RNA isolation and microarray analysis was
performed.
RNA isolation
Total RNA from each sample was extracted using the
Rneasy Mini kit (Qiagen, Valencia, CA, USA), followed
by a DNase treatment with RNase-Free DNase Set (Qia-
gen, Valencia, CA, USA). The RNA concentration was
measured using a Nanodrop ND-1000 spectrophot-
ometer (NanoDrop Technologies Inc., Wilmington, DE,
USA) and RNA quality was determined on an Agilent
2100 BioAnalyzer (Agilent Technologies, Palo Alto, CA,
USA). Measurements were performed according to the
manufacturer’s protocols. Total RNA samples with an
RNA integrity number (RIN) > 7 were used for further
analysis.
Mahabir et al. BMC Genomics 2010, 11:24
http://www.biomedcentral.com/1471-2164/11/24
Page 2 of 8Microarray analysis
Mouse oligonucleotide libraries were obtained from
Sigma-Compugen Incorporated. The libraries represent
a total of 21,825 LEADS™ clusters plus 231 controls.
The oligonucleotide libraries and additional control oli-
gos from the Lucidea™ Microarray ScoreCard™ (GE
Healthcare) were printed with a Lucidea Spotter (Amer-
sham Pharmacia Biosciences, Piscataway, NJ, USA) on
UltraGAPS slides (amino-silane-coated slides, Corning
#40017, Corning Life Sciences, Lowell, MA, USA) and
processed according to the manufacturer’s instructions.
Mouse genome microarrays were used in the analysis of
gene expression profiles of WT and Rad54/Rad54B MEFs
exposed to mutagens and clastogens (see Table 1 in the pre-
vious section). For each exposure or control group, five
RNA samples were analyzed, each of which was hybridized
to an individual microarray slide. In short, Cy3 and Cy5
labeled cRNA samples were prepared as described in the
Amino Allyl MessageAmp aRNA kit (Ambion, Austin,
Texas, USA) using 1 μg of purified total RNA and a 100 fold
dilution of Lucidea Spike-ins (GE Healthcare) as template
for the reaction. Test samples were labeled with Cy3 and
the common reference was labeled with Cy5. The common
reference was made by combining 1 μgo fe a c ht e s ts a m p l e ,
labeling 1 μg portions of this pool with Cy5 and pooling the
resulting Cy5 labeled material afterwards. 1 μgo fC y 3
cRNA was combined with 1 μg Cy5 labeled cRNA and incu-
bated for 30 minutes at 60°C in the presence of fragmenta-
tion buffer (Agilent). The fragmentized solution was mixed
in a 1:1 ratio with a 2 × hybridization buffer (Agilent) and
transferred to the microarray. A sandwich of the microarray
with a backing slide was hybridized overnight in a Surehyb
chamber. Hybridization was performed overnight according
to the Agilent, Low NA input Linear Amplification proce-
dure at 65°C. The Surehyb chamber was disassembled in
GE wash buffer 1 and washed for 1 minute at room tem-
perature and for another minute in GE wash buffer 2 at 37°
C. Microarrays were quickly dried by dipping in isopropanol
and a short spin at 230 rcf. Arrays were scanned at two
wavelengths (Cy3 and Cy5, or 532 and 633 nm, respectively)
on an Agilent G2565 microarray scanner.
Data analysis and statistics
Array Vision software (Imaging Research, St. Cathe-
rine’s, Ontario, Canada) was used to determine median
Cy3 and Cy5 signal intensities for each separate spot
and background noise. Quality control was performed
on raw data by means of visual inspection of the
scanned images, as well as a check on the scatter and
MA (ratio-intensity) plots. The control spots present on
the slide were used for quality control, but excluded
from the further analysis. Raw signal data for oligonu-
cleotide-containing spots were normalized with R soft-
ware http://www.r-project.org by using a three-step
approach [5] that consisted of (1) natural log transfor-
mation, (2) quantile normalization of all scans, (3) cor-
rection of the sample spot signal for the corresponding
reference spot signal. Raw and normalized data are
available at ArrayExpress http://www.ebi.ac.uk/arrayex-
press under accession number E-TABM-786.
Differences in gene expression between experimental
MEFs sample groups were determined by a one-way
ANOVA. Genes with a False Discovery Rate (FDR) <
0.05 and a Fold Ratio (FR) > 1.5 (between treated and
control group) were considered differently expressed.
Correlations between sets of differently expressed genes
were calculated for the union of the two sets. Enrichment
for Gene Ontology and other functional terms was deter-
mined by DAVID/EASE http://david.abcc.ncifcrf.gov[6].
Additional analyses were performed using GeneMaths
(Applied Maths, St-Martens-Latem, Belgium). Principal
Component Analysis (PCA) was performed on the aver-
age whole-genome gene expression profile of the experi-
mental groups. For clustering analysis, the merged data
of all genes regulated in at least one treatment-control
comparison were combined into a table with the appro-
priate ln-ratio/control values, which was further analyzed
using Euclidean distance and Ward linkage.
Groupwise regulation of Gene Ontology categories and
gene sets were determined by Gene Set Enrichment Ana-
lysis (GSEA) [7] using the pre-ranked GSEA option
under default analysis parameters. Gene set collections
used were the c5 (Gene Ontology) and c2 (expert
curated) gene sets provide by MsigDB http://www.broad.
mit.edu/gsea/msigdb/, and additional gene set collections
developed in house. Gene sets were considered regulated
if the GSEA p-value was < 0.05 and the FDR was < 0.25.
Results
Basal genotype gene expression differences
After microarray data normalization, Principal Compo-
nent Analysis was performed on the average gene expres-
sion profiles of the experimental groups (Figure 1). This
Table 1 Concentrations of all compounds used for the microarray experiment.
Compound Concentration Solvent CAS number
MMC (Mitomycin C) 0.2 μg/ml PBS 50-07-7
BLM (Bleomycin) 20 μg/ml PBS 9041-93-4
N-ac-AAF (N-acetoxy-2-acetylaminofluorene) 30 μM DMSO 6098-44-8
ENU (N-ethyl-N-nitrosourea) 4 mM Culture medium 759-73-9
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WT versus Rad54/Rad54B MEFs, respectively. However,
in contrast to the relatively large genotype difference sug-
gested by the PCA, only 12 genes were found to be differ-
entially expressed between these groups (FDR < 5%, FR >
1.5). GSEA analysis showed a subtle but coordinate rela-
tive down-regulation of cell division related genes in the
Rad54/Rad54B MEFs compared to the WT MEFs. Like-
wise, this genotype showed a similarly subtle but coordi-
nate trend in up-regulation of immunological pathways
and immune-cell associated genes as compared to the
WT MEFs. This indicates that the genotype separation
indicated by the PCA is due to small changes in the activ-
ity of the cell division machinery and a higher percentage
of (precursors of) immune cells. It should be mentioned
here that MEFs are derived from a large part of the
embryo and consist of a mixed cell population, contain-
ing mostly fibroblast but also other cell types. Further
GSEA analysis using cell type-specific gene sets could not
ascribe the shift in immune cell expression to specific
immunological cell lineages.
Gene expression response to mutagens
Exposure to N-ac-AAF resulted in 150 and 143 differ-
ently expressed genes in WT and Rad54/Rad54B MEFs,
respectively. The responses were highly comparable (R =
0.96) for both genotypes, as can also be seen from
Figure 2. Functional annotation showed that the stron-
gest induced genes were involved in a number of con-
nected pathways such as p53-signaling, DNA damage
response, and apoptosis (Pmaip1, Ccng1, Btg2, Mdm2,
Cdkn1a, Rprm, Perp, Bax). In addition, there was up-
regulation for a number of oxidative stress genes (Mt1,
Gsta1, Gsta2, Gsta4, Gclm). Down-regulation was
mainly observed for cell division genes (e.g. Ccnb1,
Ccnb2, Ccna2, Aurka).
ENU exposure did not result in any differently
expressed genes in WT and only 2 in Rad54/Rad54B
MEFs. Although hardly any genes were significantly regu-
lated, we did observe that the DNA damage responsive
genes regulated by N-ac-AAF showed a similar but
weaker trend upon ENU exposure (Figure 2 and Table 2).
Gene expression response to clastogens
The numbers of differently expressed genes in WT and
Rad54/Rad54B MEFs after BLM treatment were 166
and 178, respectively. Responses for both genotypes
were comparable (R = 0.75), but more different than
those observed for the mutagen exposures (see above).
Functional annotation of differentially expressed genes
showed the predominant effect was induction of genes
involved in p53-signaling, DNA damage response, and
apoptosis (Pmaip1, Ccng1, Btg2, Mdm2, Cdkn1a,
Rprm, Bbc3). Down-regulation was observed for several
cell division genes (e.g. Ccnb1, Ccnb2, Ccna2, Aurka,
Cdca3, Cdc2a, Bub1b, Cdca8). These changes were
overall similar to those observed for the mutagen
N-ac-AAF.
For MMC treatment, the numbers of differentially
expressed genes were 76 and 156 for WT and Rad54/
Rad54B MEFs, respectively. Here, the responses were
different (R = 0.29) between the MEFs of the two geno-
types. For the WT MEFs, functional annotation showed
induction of p53-signaling and DNA damage response
genes (Pmaip1, Ccng1, Btg2, Mdm2, Cdkn1a), and
down-regulation of cell division (Ccnb1, Ccnb2, Ccna2,
Ube2c, Aurka, Cdc2a) genes, in a similar manner as
seen for BLM and N-ac-AAF. For the Rad54/Rad54B
MEFs, we observed down-regulation of cell division
genes similar to that found in the corresponding WT
exposure. However, induction of p53-signaling, DNA
damage response, and apoptosis were not found in the
MMC-treated Rad54/Rad54B MEFs. Comparing these
responses among the clastogen-exposed groups showed
that these were almost absent in the MMC-treated
Rad54/Rad54B MEFs but present in the other groups
(Figure 2 (indicated as a black block) and Table 2). This
latter finding was confirmed in the GSEA results: the
canonical p53-related pathways in the MsigDB C2 data-
base all showed a significant pathway-level induction
for the different treatment vs control comparisons;
except for the MMC exposed Rad54/Rad54B MEFs
Figure 1 Principal component analysis on genome-wide
expression profiles for the experimental groups. CW: WT MEFs -
untreated, CR: Rad54/Rad54B MEFs - untreated, (circle); AW:W T
MEFs - N-ac-AAF, AR: Rad54/Rad54B MEFs - N-ac-AAF, (diamond);
EW: WT MEFs - ENU, ER: Rad54/Rad54B MEFs - ENU, (square); BW:
WT MEFs - BLM, BR: Rad54/Rad54B MEFs - BLM, (triangle); MW:W T
MEFs - MMC, MR: Rad54/Rad54B MEFs - MMC (inverted triangle).
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> 0.25.
Gene expression response comparison clastogens
to mutagens
Comparing the gene expression changes for mutagen and
clastogen exposed MEFs showed a cluster of commonly
regulated genes for all the exposures except for the
MMC-treated Rad54/Rad54B MEFs. This cluster is indi-
cated in Figure 2 with a black bar. Additionally, for both
BLM and MMC exposed MEFS, gene expression down-
regulations were found that were not (or less) present in
mutagen exposed MEFs of both genotypes (Figure 2).
Functional annotation showed that the majority of the
genes involved are either involved in immunological
pathways or known immune cell markers. Interestingly,
these genes show a stronger down-regulation in the
Rad54/Rad54B than in the WT MEFs, indicating that
this phenomenon is linked to the higher proportion of
immune cells in the Rad54/Rad54B MEFs. Clustering
also revealed an increase in extracellular matrix gene
expression in the clastogen treated MEFs, which was very
pronounced in the Rad54/Rad54B MEFs but less induced
or even down-regulated in WT MEFs (Figure 2). As
extracellular matrix genes are highly expressed in fibro-
blast this indicates a relative enrichment for fibroblast
mRNA when compared to the down-regulation of
immune cell mRNA in the total mRNA fraction.
Discussion
We have previously demonstrated that WT and Rad54/
Rad54B MEFs were able to detect both mutagen and
clastogen activity using lacZ as a reporter gene. For the
Figure 2 Hierarchical clustering of gene expression changes in WT and Rad54/Rad54B MEFs after mutagen or clastogen exposure.
Expression changes are given relative to the corresponding control, where red represents up-regulation, green down-regulation and yellow no
difference in gene expression levels. The black bar indicates the cluster showing the strongest genotype-dependent effect for the MMC-exposed
MEFs. Exposures are as follows: AW: WT MEFs - N-ac-AAF, AR: Rad54/Rad54B MEFs - N-ac-AAF, EW: WT MEFs - ENU, ER: Rad54/Rad54B MEFs -
ENU, BW: WT MEFs - BLM, BR: Rad54/Rad54B MEFs - BLM, MW: WT MEFs - MMC, MR: Rad54/Rad54B MEFs - MMC.
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observed an increase in lacZ mutant frequency in the
Rad54/Rad54B MEFs compared to the WT MEFs. This
confirms that different types of clastogens exist, which
cause genotype-dependent differences in genetic
damage. To investigate whether these differences are
reflected in triggering differences in genotoxicity
response pathways, we examined gene expression
changes in WT and Rad54/Rad54B MEFs upon expo-
sure to two types of clastogens, two mutagens and unex-
posed controls.
PCA analysis shows that an overall genotype-depen-
dent difference exists between all WT versus all Rad54/
Rad54B MEFs. A combination of statistical analysis at
the gene expression level and a threshold-free whole-
genome analysis (GSEA) showed that these differences
could be ascribed to a combination of lower activity of
cell division genes and an increase in the proportion of
immune cells in the Rad54/Rad54B MEFs compared to
the WT MEFs. The presence of immune cells among
mouse embryonic fibroblast cells can be explained
because MEFs are not exclusively derived from
fibroblast containing tissues. Instead, MEFs originate
from a larger part of the embryo, excluding liver and
head but including immunologically relevant tissues. By
the choice of culturing conditions, further MEF culture
selects for fibroblast cells. However, this selection will
not be complete and some immune cells remained pre-
sent in the MEFs used for the experiments, especially
those described for Rad54/Rad54B MEFs.
PCA visualization of the whole-genome data (Figure 1)
shows a similar shift in both direction and length for the
gene expression profiles for each compound compared
to their respective control. In the case of ENU exposed
MEFs the overall effect is small and for these exposures
hardly any significantly regulated genes were found in
MEFs of both genotypes. Clastogen-exposed MEFs (both
MMC and BLM) show an overall similar trend in the
PCA and were different for the N-ac-AAF-exposed
MEFs, indicating that there is a difference in gene
expression response after mutagens and clastogens
exposure.
For most of the exposures, a broad-scale DNA
damage response was observed. This included genes
Table 2 Gene expression changes for DNA damage response and cell cycle genes in WT and Rad54/Rad54B MEFs after
exposure to mutagens and clastogens.
Gene
symbol
Alias WT
1 -
N-ac-AAF
Rad
2 -
N-ac-AAF
WT - ENU Rad - ENU WT - BLM Rad - BLM WT - MMC Rad - MMC
Pmaip1 Noxa 3.26* 2.40 1.39 1.29 4.12* 2.86* 2.26 -1.02
Ccng1 2.74* 2.00* 1.77 1.28 2.99* 2.13* 1.54 -1.11
Btg2 2.46* 1.68* 1.59 1.09 2.77* 1.75* 1.55 1.13
Mdm2 6.37* 3.40* 2.21 1.54 3.08* 1.95* 1.99 1.08
Cdkn1a P21 4.20* 2.81* 2.09 1.54 3.06* 2.00* 1.67 1.35
Rprm 2.41* 2.37* 1.21 1.31 2.50* 1.97* 1.14 1.38
Perp 1.54* 1.40 1.07 1.08 1.48 1.46 1.05 1.08
Bax 1.55* 1.52* 1.14 1.29 1.50 1.40 1.25 -1.05
Bbc3 Puma 1.34 1.24 1.16 1.10 1.54* 1.33 1.41 1.11
Mgmt 1.01 1.06 1.15 1.16 1.72* 1.29 1.07 -1.08
Ccnb1 -1.63* -1.78* 1.07 1.20 -1.6* -1.43 -1.58 -1.61
Ccnb2 -1.64* -1.56* -1.08 1.16 -1.67* -1.48 -1.79* -1.42
Plk1 -1.55 -1.72* 1.07 1.19 -2.00* -1.57* -2.04* -1.51
Ccna2 -1.24 -1.37 1.07 1.16 -2.01* -1.43 -1.58* -1.38
Ube2c -1.25 -1.48 1.25 1.23 -1.44 -1.42 -1.70* -1.58
Aurka -1.28 -1.59* 1.29 1.22 -1.81* -1.50* -1.71* -1.58*
Cdkn3 -1.44 -1.45 -1.01 1.16 -1.48 -1.22 -1.53* -1.24
Cdca3 -1.31 -1.39 -1.00 1.17 -1.51* -1.32 -1.44 -1.38
Cdc2a -1.16 -1.22 1.18 1.27 -1.64* -1.33 -1.56* -1.44
Bub1b -1.10 -1.31 1.10 1.07 -1.67* -1.43 -1.49 -1.27
Cdca8 -1.12 -1.29 1.17 1.11 -1.57* -1.32 -1.34 -1.35
Cdkn2d P19 -1.24 -1.17 1.10 1.45 -1.47 -1.26 -1.65* -1.04
Cdkn2c P18 1.05 -1.05 1.19 1.42 -1.59* -1.34 -1.60* -1.09
1WT are wild-type MEFs treated with the different compounds
2Rad are Rad54/Rad54B MEFs treated with the different compounds
*An asterisk indicates a significant regulated gene (at FDR < 5% and ratio > ± 1.5)
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Perp, Bax, Bbc3), cell cycle arrest (Ccng1, Btg2, Mdm2,
Cdkn1a, Rprm), and DNA repair (Mgmt); with a role
for p53 in their activation being a common factor.
Responses in these genes lead to temporarily cell cycle
arrest and DNA repair or apoptosis. In line with this
finding, we also observed a down-regulation of cell divi-
sion genes for most of the exposures. Induction of oxi-
dative stress genes was only found for the N-ac-AAF
exposed cells by means of induction of several GST
enzymes. Although oxidative stress plays a role in indu-
cing genotoxicity, the response found here can also be
part of a general protection mechanism against this
compound. Exposure to clastogens, but not mutagens,
resulted in a relative down-regulation of immune cell-
associated genes and a relative up-regulation of fibro-
blast-associated genes. Both these effects were more
pronounced in the Rad54/Rad54B MEFs as compared
t ot h eW TM E F s .T h er e l a t i v ed o w n - r e g u l a t i o no f
immune cell-associated genes suggests that immune
cells and their precursors are more sensitive to clasto-
gen exposure than to mutagen exposure. The higher
proportion of immunological cells in the Rad54/Rad54B
MEFs population provides an explanation for the
enhanced effects observed for this genotype. The rela-
tive up-regulation of extracellular matrix genes can be
explained in that a lower presence of immune cell-
derived mRNA in the total mRNA fraction leads to a
relative increase for mRNA highly expressed in other (e.
g. fibroblast) cells. This is consistent with the finding
that this effect is also more pronounced in the Rad54/
Rad54B genotype than WT MEFs. It should be noted
that the differences in cell composition, and therefore
transcriptional changes in lineage specific genes upon
treatment, are not necessarily related to genotype-
dependent differences between WT and Rad54/Rad54B
MEFs. As MEFs are not clonal in their origin, some var-
iations in cell composition between isolations are inher-
ent to the use of such cells. Transcriptional changes in
cell lineage specific genes reflect the natural variation
between MEF batches coinciding with different sensitiv-
ities between cell lineages to different (classes of) geno-
toxic compounds.
The concentrations used in the experiment were cho-
s e nt or e s u l ti nc o m p a r a b l ee f f e c t so ns u r v i v a la n d
indeed the WT response for N-ac-AAF, BLM, and
MMC was found to give similar degrees of gene expres-
sion changes. In contrast, ENU gave much weaker gene
expression changes in both MEF genotypes. A possible
explanation for this could be the half life of ENU which
is approximately 1 hour in culture medium [8]. The
gene expression changes were measured 8 hours after
treatment with the different compounds. Since ENU
only has a half-life of 1 hour, most of its reactivity will
have disappeared within the first few hours after expo-
sure. The remaining time gives the cells the ability to
r e s t o r et h eD N Ad a m a g ec a u s e db yE N Ue x p o s u r e .
Therefore, there will be no or a very low effect mea-
sured of the ENU exposure 8 hours after treatment.
This was seen as both ENU treated as well as untreated
samples showed quite similar gene expression changes
in both WT as well as Rad54/Rad54B MEFs.
Effects for the N-ac-AAF treatments in WT and
Rad54/Rad54B MEFs were similar in their response,
and the response for ENU treatment was virtually
absent in MEFs of both genotypes. Therefore, it can be
said that mutagens give the same gene expression
response in both WT and Rad54/Rad54B MEFs. For the
clastogen treatments, however, this was not the case.
For the BLM treatment, the response was moderately
similar, albeit comparable (R = 0.75) for MEFs of both
genotypes. An even stronger difference was found for
after MMC treatment (R = 0.29) between MEFs of both
genotypes. Thus, the response for Rad54/Rad54B MEFs
is different from the WT response to clastogens, making
it (at least partially) clastogen specific. Remarkably, in
addition to differences in gene expression profiles after
clastogen and mutagen treatment, there is also a differ-
ence between the two clastogens used (BLM and
MMC). The major difference between the responses to
BLM and MMC lies in a weaker response through the
p53-signaling pathway upon MMC exposure of Rad54/
Rad54B MEFs, whereas the reduction in cell division
genes was not affected.
The reduction in p53-signaling pathway genes for
MMC, though not for BLM, is in line with our previous
finding that two types of clastogens exist [4]. One
including BLM and g-radiation, acting mainly through
single- and/or double-strand breaks, that can be
repaired equally effective in cells with and without active
HR repair. MMC on the other hand belongs to a class
that causes DNA crosslinks which show a differential
effect in WT versus HR-repair-deficient cells. All these
findings indicate that MMC damage repair is HR depen-
dent. In this study, the MMC response deviates between
WT and Rad54/Rad54B MEFs compared to the BLM
response. The reduced p53-signaling after MMC expo-
sure in Rad54/Rad54B MEFs could provide a mechanis-
tic explanation for the increased lacZ MF after MMC
exposure [4], as an impaired DNA damage response will
lead to a weaker DNA repair response and therefore a
larger percentage of the cells will carry a lacZ mutation.
T h i ss t u d yp r o v i d e se v i d e n c et h a tt h ed i f f e r e n c ei n
DNA damage response between BLM and MMC is
caused by insufficient p53-signaling at the gene expres-
sion level, presumably due to lack of DNA crosslink
damage recognition in MMC-exposed Rad54/Rad54B
MEFs. This suggests that HR is not only necessary for
Mahabir et al. BMC Genomics 2010, 11:24
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Page 7 of 8crosslink repair, but that the Rad54 and/or Rad54B
genes are involved in DNA crosslink damage
recognition.
Conclusions
In this study, we used WT and DNA repair deficient
Rad54/Rad54B MEFs to study transcriptional responses
to two different clastogens; bleomycin (BLM), which
causes chromosomal breaks, and the crosslinking agent
mitomycin C (MMC). The mutagens N-acetoxy-2-acety-
laminofluorene (N-ac-AAF) and N-ethyl-N-nitrosourea
(ENU) induced similar gene expression changes in
MEFs of both genotypes, however, the two clastogens
triggered different responses. In MMC-exposed Rad54/
Rad54B MEFs we could not detect a p53-dependent
response to genotoxic offens e ,w h i c hw a sa se x p e c t e d
normally induced in MMC-exposed WT MEFs as well
as in BLM-exposed MEFs being either repair deficient
or proficient. This study is in line with our previous
study [4] and lends further support to our hypothesis
that different types of clastogens exist. This can have
implications for compound hazard identification.
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